PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 23: Articles 11001-11500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Male contraception.
  2. Male contraception: achievement of reversible azoospermia by combined gonadotropin releasing hormone antagonist and testosterone enanthate.
  3. Male contraceptive -- the biological compatibility evaluation of hydrogel HFMC.
  4. Male involvement in family planning in Sierra Leone.
  5. Male involvement in family planning: an overview.
  6. Male opinion leaders eager to play a role in promoting family planning in Cameroon.
  7. Male participation in family planning in Ghana: Planned Parenthood Federation of Ghana.
  8. Male participation in family planning: a review of programme approaches in Africa.
  9. Males at high risk of HIV and their partners' contraceptive decision-making and utilization.
  10. Management of family planning emergencies.
  11. MCH promotes family planning.
  12. Measuring the unmet need for contraception: comment on Bongaarts.
  13. Mechanisms of hormonal and antihormonal action of contraceptive progestins at the molecular level.
  14. Media communication in the family planning programme in Zimbabwe.
  15. Media exposure and family planning practices in Indonesia.
  16. Medical aspects of oral contraceptive discontinuation.
  17. Medical barriers to access to family planning.
  18. Medical barriers to access to family planning.
  19. Meeting the Sexual Health Needs of Women and Men: Exploring Integration of Family Planning, AIDS and STD Programs, Hyatt Regency Crystal City, Arlington, Virginia, Regency Ballroom D, June 18-19, 1992. Proceedings. Co-sponsored by the U.S. Agency for International Development and the William and Flora Hewlett Foundation.
  20. Meeting women's needs for post-abortion family planning: framing the questions.
  21. Memorandum of Understanding Between the Government of the Socialist Republic of Vietnam and the Government of the Republic of Indonesia Concerning the Cooperation in the Field of Population and Family Planning [11 April 1992]
  22. Men and family planning in Kenya: alternative policy intervention strategies for reducing population growth.
  23. Men in Bangladesh play a role in family planning.
  24. Men in family planning: changing the world one life at a time.
  25. 1985-1992: after seven years of the Population / Family Planning Program in the Gitarama prefecture: status and prospects. [1985-1992: sept ans deja du programme de Population / PF en prefecture de Gitarama: bilan et perspectives.]
  26. 1991 contraceptive social marketing statistics.
  27. 1991 Mauritius Contraceptive Prevalence Survey: preliminary report.
  28. 20 years of a sex education clinic. Are family planning centers still needed? [Klinikk for seksuell opplysning 20 ar. Fortsatt behov for prevensjonsveiledningskontorer?]
  29. 25 years in Turkish family planning: a conversation with Ayse Akin Dervisoglu, M.D.
  30. 40 years of Pro Familia: history and future of a family planning organization. [40 Jahre Pro Familia: Geschichte und Zukunft einer Familienplanungsorganisation.]
  31. Abortion on the Supreme Court agenda: Planned Parenthood v. Casey and its possible consequences.
  32. Acceptability and use of family planning services by refugee Haitian women in Miami.
  33. Acceptability of a new intravaginal barrier contraceptive device (FEMCAP)
  34. Acceptability of Norplant-2 rods as a method of family planning.
  35. Acceptance and use of contraceptive methods in Rwanda in 1991. [Acceptation et utilisation des methodes contraceptives au Rwanda en 1991.]
  36. The acceptance of a 7-week cycle with a modern low-dose oral contraceptive (Minulet)
  37. Access to family planning is increasing, report says.
  38. Accessibility and availability of family planning services in Pakistan: 1992.
  39. Adolescent causal attributions and their relationship to sexual and contraceptive behavior.
  40. Adolescent use of contraceptives.
  41. Adverse ocular reactions to oral contraceptive use. [Le point sur les complications oculaires de la contraception orale.]
  42. Advice on contraception around the menopause.
  43. African-American adolescent females' choice and use of contraceptives.
  44. Age of entry into marriage and the date of the initiation of voluntary birth control.
  45. Agreement between oral contraceptive users and prescribers: implications for case-control studies.
  46. AIDS and family planning counseling of psychiatrically ill women in community mental health clinics.
  47. AIDS and family planning.
  48. Albania: family planning available.
  49. All my children. Family planning and trash T.V.
  50. All these contraceptives, videos and that: young people talking about school sex education.
  51. Alternate scenarios for population control in Pakistan: the issue of contraceptive method mix.
  52. Alternate scenarios for population control in Pakistan: the issue of contraceptive method mix.
  53. Alternative strategies for promoting use of spacing family planning methods: report of a national workshop, New Delhi, April 8-9, 1992.
  54. Among Native American teenagers, sex without contraceptives is common.
  55. An analysis of contraception among Chinese women in the past 20 years.
  56. An analysis of the causes for avoiding contraception among Chinese women.
  57. Annual report: statistics on family planning activities, 1989] [Rapport annuel: statistiques des activites de planning familial. Annee 1989.]
  58. Antiprogestogens: from abortion to contraception.
  59. Appeal to increase religious tolerance for contraception [letter]
  60. Arab world asks for help, but will family planning community answer?
  61. Are communities willing to participate in family planning programs? Results from a four country study.
  62. Are current prescribing practices for contraceptives an obstacle to their wider use?
  63. Assessing family planning cost-effectiveness: applicability of individual demand-programme supply framework.
  64. Assessing legal and regulatory reform in family planning: manual on legal and regulatory reform.
  65. Assessing the relation between the quality of care and the utilization of family planning services in Cote d'Ivoire.
  66. Assessment of a new modified soft jelly capsule containing nonoxynol as spermicide contraceptive.
  67. Attitudes and motivation for use of voluntary surgical contraception in five Nigerian cities.
  68. Attitudes of male adolescents towards contraception and AIDS prevention.
  69. Awareness of the dimensions of the population explosion and awareness of the means of family planning among lower socio-economic class women in Pune, India.
  70. Bangladesh Contraceptive Prevalence Survey 1991. Draft key tables.
  71. Bangladesh Contraceptive Prevalence Survey 1991: key findings.
  72. A case of panic disorder induced by oral contraceptive.
  73. A case of parkinsonism induced by an oral contraceptive.
  74. A case study on factors affecting use, acceptance and non-acceptance of contraception.
  75. Catalogue of family planning service delivery guidelines. An inventory of policies and procedures.
  76. Cerebral infarctions in women using oral contraceptive drugs. Early cerebral angiographic data [letter]
  77. Cervical cytologic profile of family planning acceptors aged around thirty years.
  78. Cervical ripening and drug dilatation for birth control operations.
  79. Chad: technical assistance in focus group discussion research on family planning.
  80. Challenges. Family Planning Association of India strategic plan 1992-2000.
  81. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
  82. Changes in contraceptive practice in a multiracial urban-based community over a ten-year period.
  83. Changes in serum levels of lipid and lipoprotein fractions during breast feeding under the effect of hormonal contraceptives. [A lipid es a lipoprotein frakciok szerum szintjenek valtozasa a szoptatas alatti hormonalis fogamzasgatlas hatasara.]
  84. Changes in the contraceptive method mix during fertility decline: Latin America and the Caribbean. [Cambios en la combinacion de metodos anticonceptivos durante la transicion de la fecundidad: America Latina y el Caribe.]
  85. Characteristics and attitudes of early contraceptive implant acceptors in Texas.
  86. Child abuse as an inhibiting factor for family planning.
  87. Childbearing and contraceptive-use plans among women at high risk for HIV infection -- selected U.S. sites, 1989-1991.
  88. Childbearing and use of oral contraceptives: impact of educational level. The Nordland Health Study.
  89. China's family planning program: challenging the myths.
  90. Choice of contraception for the individual, teenagers, lactating mothers and middle-aged women.
  91. Choice of contraceptives.
  92. Choice of injectables in family planning programmes.
  93. Choices in childbearing: when does family planning become population control?
  94. Claims to asylum or withholding of deportation made by aliens fleeing coercive family planning policies [3 November 1992]
  95. Clinical and metabolic considerations of long-term oral contraceptive use.
  96. Clinical aspects of the new contraceptive pill containing gestodene. [Aspectos clinicos de la nueva pildora con gestodeno.]
  97. Clinical observation on long acting oral contraceptives levonorgestrel plus quinestrol.
  98. Clinical study of the lactational amenorrhoea method for family planning.
  99. Collaboration between government and non-government organizations for maternal health and family planning programs.
  100. Combined oral contraception.
  101. Combining family planning and child immunization in Togo.
  102. Commercial contraceptive manufacturers and CSM implementing agencies team up in SOMARC's Latin America Regional Workshop.
  103. Communication development and family planning programs, Thailand.
  104. Communication key for family planning.
  105. Communication strategies in family planning. Information campaign, Senegal (1988-1989) [Strategies de communication en planification familiale. Campagne d'information Senegal (1988-1989)]
  106. Community based distribution in family planning.
  107. Community based distribution of family planning: some correlates of performance.
  108. Community-based factors affecting contraceptive discontinuation: an anthropological study.
  109. Community-based family planning services in Africa: the programme manager's perspective.
  110. Community-based family planning services: insights from the Kenyan experience.
  111. Community-based family planning services: insights from the Kenyan experience.
  112. Comparative assessment of two low-dose oral contraceptives, Lo-Femenal and Lo-Estrin, in Mexican women.
  113. Comparative evaluation of the effect of mono-, bi- and tri-phasic oral contraceptive pills on the endometrium. [A mono, bi- es trifazisu oralis fogamzasgatlo tablettak endometriumra gyakorolt hatasanak osszehasonlito vizsgalata.]
  114. Comparative study of the effectiveness of continuous or intermittent courses of a phlebotonic drug on venous disorders disclosed or aggravated by oral, estrogen-progesterone contraceptives. [Etude comparative de l'efficacite des cures continues ou discontinues d'un phlebotonique sur les troubles veineux reveles ou aggraves par la contraception orale estroprogestative.]
  115. A comparison of contraceptive usage by HIV infected and non-infected women one year post delivery [tables]
  116. Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception.
  117. Compulsory contraception as a condition of probation: the use and abuse of Norplant.
  118. Concentration of fat, protein, lactose and energy in milk of mothers using hormonal contraceptives.
  119. The concept of family planning and its influence on the formation and administration of state regulations in the USSR. [Le concept de la planification de la famille et son influence sur la pratique de la gestion d'etat en URSS.]
  120. Conception and misconceptions: community views on family planning.
  121. Condom use by women with Norplant contraceptive implants.
  122. Connotative meanings assigned to contraceptive options.
  123. A consensus statement: enhancing patient compliance and oral contraceptive efficacy.
  124. Considerations in the acceptance of family planning in Rwanda. [Quelques considerations sur l'acceptation de la planification familiale au Rwanda.]
  125. Consistency between estimates of contraceptive prevalence rates based on service statistics and surveys in Gujarat State, India.
  126. Constraints on supply and demand for family planning: evidence from rural Bangladesh.
  127. Continuation and discontinuation of family planning at the Centre Universitaire de Sante Publique. [Continuation et abandon de la planification familiale au Centre Universitaire de Sante Publique.]
  128. Continuation and termination rates of some contraceptive methods in two districts of Ankara, Turkey.
  129. Contraception - abortion: profile of French women. Report. [Contraception-IVG: le profil des francaises. Reportage.]
  130. Contraception after thirty-five.
  131. Contraception and abortion from the ancient world to the Renaissance.
  132. Contraception and factors influencing contraception among rural women.
  133. Contraception and prevalence of sexually transmitted diseases among adolescents and young adults in Uganda.
  134. Contraception and safer sex.
  135. Contraception and the big "C".
  136. Contraception boom points to break-through in reproductive health.
  137. Contraception during lactation.
  138. Contraception for midlife women.
  139. Contraception for the postpartum woman.
  140. Contraception for the transitional years of women older than 40 years of age.
  141. Contraception for the under 16s [letter]
  142. Contraception for the under 16s [letter]
  143. Contraception for women over 35 years of age.
  144. Contraception in adolescents. [Anticoncepcion en adolescentes.]
  145. Contraception in Belgium: differences between Wallonia and Flanders in an European perspective. [Contraception en Belgique: les differences entre la Wallonie et la Flandre dans une perspective europeenne.]
  146. Contraception in the adolescent. [La contraception chez l'adolescent.]
  147. Contraception in the latter part of reproductive life.
  148. Contraception in the perimenopause.
  149. Contraception in young subjects. [Anticonceptie bij jongeren.]
  150. Contraception is the best development.
  151. Contraception outside North America: options and popular choices.
  152. Contraception with Norplant, a subdermal implant. [Contraception par un implant sous-cutane, le Norplant.]
  153. Contraception, abortion and sexually transmitted diseases. [Prevensjon, abort og seksuelt overforbare sykdommer.]
  154. Contraception.
  155. Contraception. Family planning: by whom and for whom?
  156. Contraception. Not as safe as you think.
  157. Contraception: what choice and for what kind of life? Women's stories and doctors' statements. [Contraception: quel choix pour quelle vie? Recits de femmes, paroles de medecins.]
  158. Contraception: hormonal and barrier methods.
  159. Contraception: methods, effectiveness, choice, contraindications, monitoring, risks. [Contraception: methodes, efficacite, choix, contre-indications, surveillance, risques.]
  160. Contraceptive choice: a multitude of meanings.
  161. Contraceptive continuation in students attending six school-based clinics in Baltimore City.
  162. Contraceptive costs in the nineties: a comparative cost-benefit study of the Norplant system (levonorgestrel implants]. An important method of birth control.
  163. Contraceptive development.
  164. The contraceptive effect of breast feeding. [Kontrazeptive Wirkung des Stillens.]
  165. Contraceptive efficacy of lactational amenorrhoea.
  166. Contraceptive efficacy of polyester-induced azoospermia in normal men.
  167. Contraceptive failure among 720 adolescents requesting induced abortion. [L'echec contraceptif chez 720 adolescentes demandant une interruption de grossesse.]
  168. Contraceptive failure rates based on the 1988 NSFG.
  169. Contraceptive failure rates in Turkey.
  170. Contraceptive in the climacteric. [Kontrazeption im Klimakterium.]
  171. Contraceptive method mix: the importance of ensuring client choice.
  172. Contraceptive practice in Ghana: does partner's attitude matter?
  173. Contraceptive prevalence in Haiti remains low; use of modern methods rises.
  174. Contraceptive prevalence rates low in Guatemala: use is much more likely among working women.
  175. Contraceptive prevalence, reproductive health, and international morality.
  176. Contraceptive requirements and logistics management needs in Pakistan.
  177. Contraceptive requirements and logistics management needs in Zimbabwe.
  178. Contraceptive research: still inadequate after all these years?
  179. Contraceptive retail sales in the Family Planning Association of Sri Lanka.
  180. Contraceptive services: a client's choice.
  181. Contraceptive social marketing in Turkey.
  182. The Contraceptive Social Marketing Project: retrospective study. [Le projet de marketing social des contraceptifs: etude retrospective.]
  183. Contraceptive social marketing sales report, 1st quarter 1992.
  184. Contraceptive social marketing sales report, 2nd quarter 1992.
  185. Contraceptive sponge fails to prevent heterosexual transmission of HIV among prostitutes in Kenya.
  186. Contraceptive steroids and the mammary gland: is there a hazard? Insights from animal studies.
  187. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
  188. Contraceptive Technology Education Project.
  189. Contraceptive use and commodity costs in developing countries, 1990-2000.
  190. Contraceptive use and fertility in Gujarat.
  191. Contraceptive use and sterilization among Puerto Rican women.
  192. Contraceptive use in Indonesia: a history of the programme and the characteristics of users.
  193. Contraceptive use in Matlab, Bangladesh in 1990: levels, trends, and explanations.
  194. Contraceptive use in Matlab, Bangladesh: the role of gender preference.
  195. Contraceptive use in Vietnam: the effect of individual and community characteristics.
  196. Contraceptive use projections: 1990 to 2010.
  197. Contraceptive vaccines: promises and problems.
  198. Contraceptives containing desogestrel or levonorgestrel have different effects on serum lipoproteins and post-heparin plasma lipase activities.
  199. Contraceptives: demand rising. [Anticonceptivos: demanda en ascenso.]
  200. Contribution of some socio-economic variables towards explaining the level of adoption of various family planning devices in India during 1987.
  201. The control of reproduction: contraception and abortion in France and Czechoslovakia. [La maitrise de la procreation: contraception et avortement en France et en Tchecoslovaquie.]
  202. Controlled release contraceptive devices: a status report.
  203. Correlates of family planning acceptance: a multivariate analysis.
  204. Cost and self-reliance in family planning: a short comment.
  205. The costs of contraceptive social marketing programs implemented through the SOMARC project.
  206. The costs of contraceptive social marketing programs implemented through the SOMARC project.
  207. Costs of family planning services delivered through PROFAMILIA programs. Final report.
  208. Costs of family planning services: a critique of the literature.
  209. Counseling guide on voluntary surgical contraception [VSC]
  210. Counseling postpartum women about contraception.
  211. Couple's literacy level and acceptance of family planning methods: Lorenz curve analysis.
  212. The creation of family planning service stations in China.
  213. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
  214. Cultivation effects and contraception, pregnancy, and negative consequences of sexual behaviors in daytime soap operas: a content analysis and survey.

     

  215. Cultural factors in oral contraceptive compliance.
  216. Current developments in hormonal contraception. [Aktuelle Entwicklungen in der hormonalen Kontrazeption.]
  217. Current oral contraceptive use instructions: an analysis of patient package inserts.
  218. Current status and prospects of family planning in black Africa. [Situation actuelle et perspectives en matiere de planification familiale en Afrique noire.]
  219. Current status of contraceptive vaginal rings. [Etat actuel des anneaux vaginaux contraceptifs.]
  220. Cyclofem: a new once-a-month injectable contraceptive.
  221. Decision on improving family planning work, 1992]
  222. Decree No. 92-784 of 6 August 1992 on family planning or family education centers. [Decret no. 92-784 du 6 aout 1992, relatif aux centres de planification ou d'education familiale.]
  223. Decree of the State Family Planning Commission of the People's Republic of China (No. 1, December 26, 1991). Measures for the management of family planning of the floating population.
  224. Defining an appropriate contraceptive method mix to meet fertility preferences.
  225. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
  226. Delaying pelvic exams to encourage contraceptive use.
  227. The demand for family planning: estimates for developing countries.
  228. Demographics of adolescent sexual behavior, contraception, pregnancy, and STDs.
  229. Depo medroxyprogesterone acetate (Depo Provera) for contraception. Remarks.
  230. Depo-Provera. Controversial contraceptive wins approval from FDA panel.
  231. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
  232. Designing a family planning user fee system: a handbook for program managers.
  233. Determinants of acceptance of injectable contraception in Bangladesh.
  234. Determinants of acceptance of injectable contraception in Bangladesh.
  235. Determinants of contraceptive choice among single women in the United States.
  236. Determinants of contraceptive continuation in rural Bangladesh.
  237. Determinants of contraceptive knowledge and family planning services in Bangladesh.
  238. Determinants of contraceptive use dynamics in Thailand: an analysis of contraceptive status calendar.
  239. Determinants of current contraceptive use among Ghanaian women at the highest risk of pregnancy.
  240. Determinants of male involvement in family planning and contraceptive use in Sub-Saharan Africa. Highlights of a research proposal.
  241. Developing more effective family planning, family health and family welfare programmes: opportunities for government-NGO collaboration. Executive summary and policy implications.
  242. Developing partnerships to upgrade the quality of contraceptive service delivery in Thailand.
  243. Development and evaluation of a CAI program on contraception.
  244. Development family planning standards of practices and procedures guidelines.
  245. Development of contraceptives: general concerns. Contraceptive research: women's perspectives.
  246. Development of Hungarian oral contraceptives. [A magyar fogamzasgatlo tablettak korszerusodese.]
  247. Development of the Zimbabwe family planning program.
  248. The development, expansion, and sustainability of urban family planning services in the Republic of Mali.
  249. Developments in male contraception.
  250. Diagnostic study of the major NGOs in family planning.
  251. Dimensions of new contraceptives. Norplant and poor women.
  252. Dimensions of the contraceptive attributes questionnaire.
  253. A direct immunoradiometric assay for human plasma prorenin: concentrations in cycling women and in women taking oral contraceptives.
  254. Directory of hormonal contraceptives. 2nd ed. [Repertoire des contraceptifs hormonaux. Guia de anticonceptivos hormonales.]
  255. Directory of training courses in family planning and maternal and child health, 1992-93 edition. [Repertoire des cours de formation en planification familiale et sante materno-infantile, edition 1992-93. Guia de cursos de capacitacion sobre planificacion de la familia y salud materno-infantil, edicion 1992-93.]
  256. Disturbances in dexamethasone suppression test and lower availability of L-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy.
  257. Double indemnity: contraception and cancer prevention.
  258. Drug interactions with oral contraceptives [letter]
  259. Early discontinuation of contraceptive use in Niger and The Gambia.
  260. Early discontinuation of contraceptive use in Niger and the Gambia.
  261. Effect of child survival on contraceptive use in Bangladesh.
  262. The effect of drug interactions on the efficacy of oral contraception.
  263. The effect of ethnic group on sexual activities related to contraception and STDs.
  264. The effect of family planning participation on prenatal care use and low birth weight.
  265. The effect of low-dose oral contraceptives and Norplant on blood pressure and body weight of Nigerian women.
  266. The effect of migration on contraceptive usage and service point choice in Indonesia.
  267. The effect of mothercraft classes on mothers' family planning practices.
  268. Effect of oral contraceptive use on reoperation following surgery for Crohn's disease.
  269. Effect of oral contraceptive use on the incidence of impaired glucose tolerance and diabetes mellitus.
  270. Effect of oral contraceptives on plasma Beta-endorphin and corticotropin at rest and during exercise.
  271. The effect of oral ovulation inhibiting (mono-, bi- and triphase) contraceptives and of Continuin and Postinor on proteo- and steroid hormones. [Az ovulacio gatlo oralis fogamzasgatlo (mono, bi- es trifazisu) es a Continuin es Postinor hatasa a proteo- es szteroidhormonok alakulasara.]
  272. The effect of prior family planning participation on prenatal care utilization and low birth weight.
  273. Effect of programmatic and non-programmatic factors on contraception and fertility in Bangladesh.
  274. Effect of son mortality on contraceptive practice in Bangladesh.
  275. Effect of the oral contraceptive pill on protein S and antithrombin-III levels in Malaysian women.
  276. Effect of women's fertility desires and other factors on contraceptive rate.
  277. The effectiveness of postcoital hormonal contraception.
  278. The effects of a combined contraceptive vaginal ring releasing ethinyloestradiol and 3-ketodesogestrel on vaginal flora.
  279. Effects of age, sex and the oral contraceptive on the platelet membrane fibrinogen binding site (glycoprotein IIb/IIIa)
  280. Effects of oral contraceptive norethisterone compound on lipid and lipoprotein metabolism.
  281. Effects of oral contraceptives containing oestrogen combined with norethisterone or levonorgestrel on erythrocyte cation transport in normal women.
  282. Effects of oral contraceptives on hormonal and metabolic responses during exercise.
  283. Effects of steroid contraceptive on serum levels of sex hormone binding globulin in women.
  284. Effects of sub-50 oral contraceptives on homocysteine metabolism: a preliminary study.
  285. Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3. [Einflusse verschiedener Kontrazeptiva auf die Laborparameter der Schilddrusenfunktionsdiagnostik unter besonderer Berucksichtigung der freien Hormone FT4 und FT3.]
  286. Egypt Family Planning Operations Research Program, 1989 - 1992: final project report.
  287. Egypt pursues family planning.
  288. Emergency (postcoital) contraception guidelines for doctors.
  289. Emergency contraceptive pills: a simple proposal to reduce unintended pregnancies.
  290. Employment in family planning and women's status in Bangladesh.
  291. End-of-project evaluation of the Indonesia Family Planning Development and Services II Project.
  292. Endogenous estradiol and progesterone concentrations in smokers on oral contraceptives.
  293. Enhancing oral contraceptive compliance and efficacy. Proceedings of a symposium held at the European Society of Contraception Congress, Athens, Greece, 6-9 May 1992.
  294. An epidemiologic study of ovarian cancer. Part 11: Oral contraceptive use and menstrual events.
  295. Estimates of averted Chinese births, 1971-1990: comparisons of fertility decline, family planning policy, and development in six Confucian societies.
  296. Estimating contraceptive continuation from program acceptor data.
  297. The estrogenic potential of progestins in oral contraceptives in stimulating human breast cancer cell proliferation.
  298. Ethically justified guidelines for family planning interventions to prevent pregnancy in female patients with chronic mental illness.
  299. Evaluating family planning program impact in Sub-Saharan Africa.
  300. Evaluating family planning program impact: new initiatives on a persisting question.
  301. Evaluating the readability of informed consent forms used in contraceptive clinical trials.
  302. Evaluating use of a computerized contraceptive decision aid in Madison and inner-city Chicago family planning clinics.
  303. Evaluation of A.I.D. family planning programs: Kenya case study.
  304. Evaluation of A.I.D. family planning programs: Philippines case study.
  305. Evaluation of birth control pill booklet for illiterate women. Draft report.
  306. Evaluation of family planning programme.
  307. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
  308. Evaluation of the hormonal potency of the monthly injectable contraceptive with dihydroxyprogesterone acetophenide, 150 mg and estradiol enanthate, 10 mg compared with oral contraceptives. [Evaluacion de la potencia hormonal del anticonceptivo inyectable mensual de dihidroxiprogesterona acetofenido 150 mg y estradiol enantato 10 mg, comparativamente con tratamientos anticonceptivos orales.]
  309. Evaluation of the impact of IEC components of family planning programs.
  310. Family planning courses.
  311. Family planning directions after the demographic transition.
  312. Family planning education: working with target groups in the South Pacific.
  313. Family planning efforts in Turkey and the TRT.
  314. Family planning expansion project in Burkina Faso: initial community study, 1992. Preliminary report. [Projet d'expansion de la planification familiale au Burkina Faso: etude communautaire initiale 1992. Rapport preliminaire.]
  315. Family planning for women with bipolar disorder.
  316. Family planning goes public.
  317. Family planning IEC project in Ghana: impact on Ghanaian males.
  318. Family planning in Bangladesh: an emerging success story.
  319. Family planning in Bangladesh: an unlikely success story.
  320. Family planning in Benin--knowledge, attitudes and practice.
  321. Family planning in Bolivia: from talk to action. [Planificacion familiar en Bolivia: del debate a la accion.]
  322. Family planning in South Africa -- Colored people and Blacks are neglected groups. [Familjeplanering i Sydafrika -- fargade och svarta eftersatta grupper.]
  323. Family planning in the 1990s.
  324. Family planning in the armed forces.
  325. Family planning in the legacy of Islam.
  326. Family planning in the nineties: more of the same?
  327. Family planning in the United States: at the crossroads [editorial]
  328. Family Planning Information, Education and Communication Project: quarterly report, October to December 1992.
  329. Family planning knowledge, attitudes and practice among selected post-primary school students in a city in northern Nigeria.
  330. Family planning knowledge, attitudes and practices in Cameroon: baseline survey.
  331. Family planning knowledge, attitudes, and practices in 7 districts of Tanzania.
  332. Family planning legislation and policy in China.
  333. Family planning media: that's entertainment]
  334. The family planning methods.
  335. Family planning movement in Indonesia.
  336. Family planning needed for all women.
  337. Family planning operations research strategy in Egypt.
  338. Family planning policies and strategies for developing countries.
  339. Family planning policy and fertility in China: results from the 1988 Two-per-Thousand Fertility Survey.
  340. Family planning practices of migrant farm-workers: a methodological approach.
  341. Family planning program effort has increased during the 1980s, with East Asia ranked highest.
  342. Family planning program evaluation: a step-by-step guide for managers and evaluators. [Evaluacion de programas de planificacion familiar. Guia detallada para administradores y evaluadores.]
  343. Family planning program sustainability: threat or opportunity?
  344. Family planning programme in Bangladesh.
  345. Family planning programme sustainability: a review of cost recovery approaches.
  346. The family planning programme: lessons from Tamilnadu's experience.
  347. Family planning programmes and fertility effects: an overview.
  348. Family planning programmes and fertility.
  349. Family planning programmes in Bangladesh.
  350. Family planning programs in Sub-Saharan Africa: case studies from Ghana, Rwanda, and the Sudan.
  351. Family planning programs: the heritage of the 1980's, the challenges of the 1990s. [Programmes de planification familiale: l'heritage des annees 80 ... les defis des annees 90.]
  352. Family planning quality improvement initiatives in Niger.
  353. The family planning referral system.
  354. Family planning rules on itinerant people issues.
  355. Family planning saves lives.
  356. Family planning services -- use and preferences of recent mothers.
  357. Family planning services / sex education / teenage pregnancy.
  358. Family planning services / sex education / teenage pregnancy.
  359. Family planning services given to migrant workers in the Dogankent region of Cukurova University, Medical Faculty.
  360. Family planning services in the province of Mardin.
  361. Family planning strategy for the 1990s in Tunisia.
  362. Family planning success in two cities in Zaire.
  363. Family planning success stories in Bangladesh and India.
  364. Family planning without doctors.
  365. Family planning work of the Ministry of Health.
  366. Family planning, Amazon style.
  367. Family planning, obstetrical and gynecological health care provision in the Soviet Far East.
  368. Family planning, sexual health and AIDS -- the second phase.
  369. Family planning, sexually transmitted diseases and contraceptive choice: a literature update--Part I.
  370. Family planning, sexually transmitted diseases and contraceptive choice: a literature update -- Part II.
  371. Family planning. Data briefing.
  372. Family planning: the unfinished revolution.
  373. Family planning: a health and development issue.
  374. Family planning: evaluation of a health center program (1986-1990) [Planificacion familiar: evaluacion del programa en un centro de salud (1986-1990)]
  375. Family planning: future needs.
  376. Family planning: KAP among rural women in Kabarole District, Uganda [letter]
  377. Family planning: the responsibility to prevent both pregnancy and reproductive tract infections.
  378. Family planning: we cannot use what we do not understand] Qualitative research on family planning in Uganda.
  379. Family planning: what women say.
  380. Family-planning efforts succeed in Thailand.
  381. Fatal pulmonary venoocclusive disease after use of oral contraceptives.
  382. Fatal stroke and use of oral contraceptives: findings from a case-control study.
  383. FDA requirements for nonclinical testing of contraceptive steroids.
  384. A feasible example of implementation of the one-child policy in the countryside: an evaluation of the results of implementation of family planning policies in Heishan County.
  385. Female contraception by a normal dose progestogen in patients over 40 years of age. Possible combination of nomegestrol acetate / 17 Beta-estradiol by percutaneous route. [La contraception feminine par progestatif normodose apres 40 ans. Possibilite d'association acetate de nomegestrol --17-beta-estradiol par voie cutanee.]
  386. Female fieldworkers bring family planning to Ahmedabad slums.
  387. Female voluntary surgical contraception via minilaparotomy under local anesthesia.
  388. Fertility and contraceptive adoption and discontinuation in rural Kenya.
  389. Fertility and family planning in Bangladesh.

     

  390. Fertility and family planning in India and Kenya.
  391. Fertility and family planning in Latin America: challenges of the 1990s.
  392. Fertility and family planning.
  393. Fertility control experiences in the Republics of Korea and China. Proceedings of the Third Workshop on Comparative Study of Population and Family Planning in ROK and ROC, July 9-17, 1991, Taiwan, Republic of China.
  394. Fertility decline in Bangladesh: an emerging family planning success story.
  395. Fertility decline, contraceptive use, and errors in maternity histories: a study of the Indonesian Fertility Survey.
  396. Fibrinolytic activity in bleeding associated with intrauterine contraceptive devices.
  397. Fibrinolytic activity in women on oral contraceptive pills: variation due to haemoglobin genotype.
  398. Fibrinolytic response in women on low-dose oral contraceptive.
  399. Field study report. Monitoring and evaluation of the Ghana Health and Family Planning Information Project. Analysis of declining issuance of oral contraceptives.
  400. Final evaluation of the Ghana Contraceptive Supplies Project No. 641-0109.
  401. Final evaluation of three family planning subprojects under the Egypt Population / Family Planning II Project (263-0144): the Comprehensive Family Care Subproject of the Coptic Association for Social Care (CASC), the Upper Egypt Family Planning and Community Development Subproject of the Bishopric for Public, Ecumenical, and Social Services (BPESS), the Rural Community-Based Family Planning Subproject of the Coptic Evangelical Organization for Social Services (CEOSS)
  402. Final report (condensed): Users' Perspectives on the Delivery of Family Planning Services in a Model Clinic in Dakar, Senegal.
  403. Final report. A diagnosis of post model and territorial distribution of family planning service delivery points in metropolitan Lima. Contract CI19-16A. The Population Council, Instituto Andino de Estudios en Poblacion y Desarrollo (INANDEP). Volume 1.
  404. Final report. Increasing Family Planning Acceptance and Use through Improved IEC Strategies. Subagreement between the Johns Hopkins University / Population Communication Services and Family Planning Organization of the Philippines, April 1, 1988 - June 30, 1990, AS-PHI-04.
  405. Final report. Using Male Motivators to Generate Demand for Family Planning in a Male Farmer Organization. Sub-agreement between the Johns Hopkins University Population Communication Services and the Population Center Foundation, July 1987 - September 1990, AS-PHI-01.
  406. Final report: A Diagnosis of Post Model and Territorial Distribution of Family Planning Service Delivery Points in Metropolitan Lima. Contract CI19-16A, the Population Council, Instituto Andino de Estudios en Poblacion y Desarrollo (INANDEP), December 1, 1991 - January 15, 1992.
  407. Final report: Anambra State Family Planning Awareness Campaign, Project AF-NGA-15 and AF-NGA-29.
  408. Final report: Development of Field Workers' Motivational Guide, Bangladesh Project AS-BAN-06. A project undertaken by the Johns Hopkins University Population Communication Services and conducted by the Program for the Introduction and Adaptation of Contraceptive Technology. Bangladesh.
  409. Final report: Family Planning Comes First to Kwara State, Nigeria Project AF-NGA-01.
  410. Final report: Family Planning IEC and Training Materials Project, AF-GAM-01.
  411. Final report: Mali Family Planning and IEC Project, AF-MAI-01.
  412. Final report: Plateau State Family Planning Information, Education and Communication Campaign, Nigeria Project AF-NGA-03.
  413. Final report: the "Swapner Shuru" family planning film series, Bangladesh Project AS-BAN-05. Project duration: December 1, 1989 - June 30, 1990.
  414. Final report: Workshop on Evaluation of Family Planning Programs, October 5-9, 1992, Quito, Ecuador. CEMOPLAF / Ecuador Contract No. CI92.68A, October 1, 1992 - November 15, 1992.
  415. Final report: Workshop on Introduction to Operations Research in Family Planning, Development Academy of the Philippines, Conference Center, Tagaytay City, the Philippines, October 27-30, 1992.
  416. A final survey of family planning knowledge, attitudes, and practice in Brikama, The Gambia.
  417. A final survey of family planning knowledge, attitudes, and practice in Brikama, the Gambia.
  418. Financial sustainability of the Japan Family Planning Association (JFPA)
  419. Financing Family Planning Services: Is Categorical Legislation Still Needed? Drs. McFarlane and Meier Respond [letter]
  420. Financing Family Planning Services: Is Categorical Legislation Still Needed? [letter]
  421. Findings on contraceptive use effectiveness from the 1987 Thailand Demographic and Health Survey.
  422. The focus group method applied to the study of problems of contraception in the Kayes-Mopti cercles and the Bamako district, Mali. [La methode des groupes focalises (focus groups) appliquee a l'etude des problemes de la contraception dans les cercles de Kayes-Mopti et le district de Bamako - Mali.]
  423. The Food and Drug Administration today announced the approval of Depo Provera, an injectable contraceptive drug. [Press release]
  424. Forced family planning in Tibet [letter]
  425. Foreign assistance to coercive family planning in China.
  426. From fertility reduction to reproductive choice: gender perspectives on family planning.
  427. From revolution to abortion and contraception in Romania.
  428. From the National Institutes of Health: research progress on new and better methods for family planning.
  429. Gambian religious leaders teach about Islam and family planning.
  430. The Ghana Family Planning and Health Project.
  431. Ghanaian midwives have new family planning role.
  432. Glutathione peroxidase activity in a healthy Canadian population. Effects of age, smoking and drinking habits, exercise and oral contraceptive use.
  433. GNRH antagonists in men: development of a male contraceptive.
  434. Government should support family planning.
  435. Graduating NGOs to self-sustaining status and stagnating national family planning programs.
  436. Greater Ankara municipality: "Ankara Women Leaders Family Planning Project".
  437. Greatest unmet need for contraceptives seen in Sub-Saharan Africa.
  438. Guidelines and instruments for a family planning situation analysis study.
  439. Guidelines for reviewing family planning services. Guidance for regions.
  440. Guidelines for UNFPA support to family planning programmes [memorandum]
  441. Guiding principles in addressing STD / HIV prevention within family planning efforts.
  442. Guns or butter, family planning or widgets?
  443. Health (Family Planning) (Amendment) Act, 1992 [23 July 1992]
  444. Health benefits of contraception. [Ehkaisymenetelmien terveyshyodyt.]
  445. Helping patients choose an appropriate method of birth control.
  446. Helping services meet demand. An assessment of A.I.D. assistance to family planning in Kenya.
  447. Hepatobiliary complications of oral contraceptives.
  448. Hormonal contraception and substitution therapy: the importance of progestogen for cardiovascular diseases. [Hormonale Kontrazeption und Substitutionstherapie: die Bedeutung des Gestagens fur kardiovaskulare Erkrankungen.]
  449. Hormonal contraception. [La contraception hormonale.]
  450. Hormonal contraception: what's really new? [Contracepcao hormonal: o que ha de realmente novo?]
  451. The hormone diaphragm affords safe contraception and relief from menstrual pain. [Hormonikierukka antaa varman ehkaisysuojan ja vapauttaa kuukautisvaivoista.]
  452. Hormone levels and anogenital swelling of female chimpanzees as a function of estrogen dosage in a combined oral contraceptive.
  453. How access to contraception affects fertility and contraceptive use in Tunisia.
  454. How family planning can save lives in Africa.
  455. How rapid is the return of fertility after the use of Tri-Regol oral contraceptive?
  456. How reduced demand for children and access to family planning accelerated the fertility decline in Colombia.
  457. How to expand and improve the coverage of family planning services: a Latin American viewpoint. [Como aumentar y mejorar la cobertura de servicios de planificacion familiar: un punto de vista latinoamericano.]
  458. HPV genital infections and contraception.
  459. Human contraception: development of new scientific opportunities.
  460. Husbands share the responsibility for family planning.
  461. Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives.
  462. IEC strategies of family planning programmes in Korea.
  463. Immunological approach to male contraception. [Approche immunologique de la contraception chez le male.]
  464. Immunological contraception -- future possibilities in family planning. [Immunkontraception -- framtida mojlighet till familjeplanering.]
  465. The impact of a mobile drama on family planning behavior in Ogun State, Nigeria.
  466. The impact of contraception on fertility. [L'effet de la contraception sur la fecondite.]
  467. The impact of family planning employment on field workers' lives: a strategy for measuring empowerment.
  468. The impact of family planning on reproductive health. [El impacto de la planificacion familiar sobre la salud reproductiva.]
  469. Impact of family planning program inputs on use of contraceptives in Gujarat State, India.
  470. Impact of family planning program on population quality in Korea.
  471. The impact of HIV on women: gynecology, pregnancy, and family planning considerations.
  472. The impact of introducing Norplant on contraceptive use and costs: an example from Thailand.
  473. The impact of mass media family planning promotion on family planning in a sub-Saharan African country.
  474. The impact of mass media family planning promotion on family planning in Ghana.
  475. Impact of social marketing on contraceptive prevalence and cost in Honduras.
  476. The impact of strengthening clinic serkices and community education programs on family planning acceptance in rural Madagascar. Draft.
  477. Impact of the family planning program on population quality -- the case of Taiwan.
  478. The impact of women's participation in credit programs on family planning in rural Bangladesh.
  479. Implications of unmet need of family planning for policy and demographic impact: a comparative analysis of large countries.
  480. The importance of proper insertion of Norplant contraceptive implants [editorial]
  481. Improved treatment of abortion complications and post-abortion family planning in Zimbabwe.
  482. Improving family planning evaluation. A step-by-step guide for managers and evaluators.
  483. The in-vitro mucosal conjugation of ethinyloestradiol and the bioavailability of oral contraceptive steroids in patients with treated and untreated coeliac disease.
  484. Increase in 16 year olds attending family planning clinics.
  485. Increased capillary permeability for plasma proteins in oral contraceptive users.
  486. Increasingly artful. Applying commercial marketing communication techniques to family planning communication.
  487. India's family planning challenge: from rhetoric to action.
  488. India. National Workshop on Family Planning Communication, Ootacamund, Tamil Nadu, January 29-31, 1992. Workshop evaluation results.
  489. Indonesia's national family planning program: ingredients of success.
  490. The Indonesian Family Planning Programme: a success story for women?
  491. Induced abortion at Mulago Hospital Kampala, 1983 - 1987: a case for contraception and abortion laws' reform.
  492. Induced abortions in the USSR at the end of the 1980's: the basis for the national model of family planning.
  493. Infection prevention for family planning service programs: a problem-solving reference manual.
  494. Influence of attitudinal and communication variables of family planning on fertility behaviour.
  495. The influence of contraceptive costs on the demand for children.
  496. The influence of contraceptive costs on the demand for children.
  497. The influence of fieldworker quality of care upon contraceptive adoption in rural Bangladesh.
  498. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast.
  499. Influence of oral contraceptive agents on kidney function and protein metabolism.
  500. Influence of oral contraceptives on integrated secretion of gonadotropins.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.